Six COVID-19 Detector Dogs began work at the Adelaide Airpor...
SA Pathology has now opened a new collection centre within t...
On Monday 17 May 2021, SA Pathology opened a new collection ...
SA Pathology is proud to have been recognised for our world-...
SA Pathology now provides testing omega-3 levels for women w...
SA Scientists Identify Obscure Protein Responsible for Advanced Breast Cancer
26 May 2020
Research conducted by scientists in the Centre for Cancer Biology (CCB), an alliance between SA Pathology and the University of South Australia, has made a critical breakthrough, discovering how an obscure protein causes breast cancer to develop and grow more quickly.
High levels of a protein called Creld2 have been linked to the most aggressive types of breast cancer with lower survival rates, according to Associate Professor Michael Samuel, a senior UniSA researcher in the Centre for Cancer Biology (CCB), who spearheaded this research with co-lead scientist Dr Marina Kochetkova.
In a paper published in Nature Cell Biology today, the researchers describe how aggressive breast cancers produce Creld2, which hijacks healthy cells, to promote tumour progression.
"Scientists have been aware of this protein for some time, but it has not been well-studied and until now we hadn’t understood the role it plays in breast cancer. Creld2 appears to make normal, healthy cells surrounding the tumour behave abnormally, causing them to help tumours grow," Assoc Prof Samuel said.
The team at the CCB is now working on therapies to destroy or block Creld2, with the aim of stopping breast cancers from growing and spreading around the body.
High levels of Creld2 are found in triple negative breast cancers, which make up 15 per cent of all breast cancers in Australia, are difficult to treat and have the poorest survival rates. This type of breast cancer also frequently affects younger women.
Creld2 at high levels is also found in kidney cancers, non-melanoma skin cancers – the most commonly diagnosed cancer in Australia – and invasive squamous cell carcinomas, which can be deadly if not detected early.
"The prognosis for all these cancers is not good, so if we can destroy or block this protein, we could potentially stop these cancers from growing," Assoc Prof Samuel said.
Breast cancer is the most common cancer affecting women, accounting for approximately 29 per cent or 19,371 women diagnosed with cancer each year, according to Breast Cancer Network Australia. It is the second leading cause of cancer death in Australian women after lung cancer.
The paper is available at: https://www.nature.com/articles/s41556-020-0523-y
A video explaining this research can be viewed at: